influenza

Sanofi’s Supemtek Receives CHMP’s Positive Opinion for Approval to Prevent Influenza

  • by

Shots: The CHMP’s recommendation is based on two P-III studies demonstrating the safety and efficacy of Supemtek (quadrivalent recombinant influenza vaccine) in 10,000+ patients aged ≥18yrs. The company expects EC’s decision in Q4’20 Supemtek is the first and only influenza vaccine to rely on recombinant… Read More »Sanofi’s Supemtek Receives CHMP’s Positive Opinion for Approval to Prevent Influenza

Influenza Vaccine for 2020-2021

  • by

Date:  September 21, 2020 Issue #:  1607 Summary:  Annual vaccination against influenza A and B viruses is recommended for everyone ≥6 months old without a contraindication. Vaccination of all eligible persons can reduce the prevalence of influenza illness and symptoms that might be confused with… Read More »Influenza Vaccine for 2020-2021

Influenza Vaccine for 2020-2021

  • by

Date:  September 21, 2020 Issue #:  1607 Summary:  Annual vaccination against influenza A and B viruses is recommended for everyone ≥6 months old without a contraindication. Vaccination of all eligible persons can reduce the prevalence of influenza illness and symptoms that might be confused with… Read More »Influenza Vaccine for 2020-2021